SLD.AU Saluda Medical Inc
- Market cap
- AUD 62.4M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is SLD.AU undervalued?
Graham numberThe Graham number of Saluda Medical Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Saluda Medical Inc fundamental analysis
No fundamental analysis for Saluda Medical Inc yet.
Saluda Medical Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Saluda Medical Inc
Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilater…
Full company profileFinancial statements of Saluda Medical Inc are not available yet.
Saluda Medical Inc dividends
Saluda Medical Inc has not paid dividends in the last 1 fiscal years.
Who owns Saluda Medical Inc
- Insiders 15.14%
- Institutions 30.62%
- Public & others 54.24%
- Shares outstanding 255M
- Free float 107M
Saluda Medical Inc company profile
- Company name
- Saluda Medical Inc
- Ticker
- SLD.AU
- ISIN
- AU0000432114
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- June
- Address
- 9401 James Avenue S, Bloomington, MN, United States, 55431
- Phone
- (857) 272-9585
- Website
- saludamedical.com
About Saluda Medical Inc
Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. The company was founded in 2011 and is based in Bloomington, Minnesota.
Saluda Medical Inc management
5- Mr. Michael MathiasPresident, CEO & Director
- Mr. James EricksonChief Financial Officer
- Mr. Aidan O'SullivanChief Operations Officer
- Ms. Kristin S. CapliceChief Legal Officer & Secretary
- Mr. David FirstChief People Officer · born 1964